Page last updated: 2024-08-23

cabergoline and Diabetes Mellitus, Type 2

cabergoline has been researched along with Diabetes Mellitus, Type 2 in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Akhtar, MF; Akter, R; Al-Harrasi, A; Berrada, M; Bhatia, S; Damiri, F; Ferdous Mitu, J; Kabir, MT; Rahman, MH; Rahman, MS; Saleem, A	1
Lamos, EM; Levitt, DL; Munir, KM	1
Akha, O; Ala, S; Bahar, A; Daneshpour, E; Kashi, Z	1
Fatemi, SS; Rokni, H; Taghavi, SM	1
Ali, O; Banerjee, S; Kelly, DF; Lee, PD	1

Reviews

2 review(s) available for cabergoline and Diabetes Mellitus, Type 2

Article	Year
Therapeutic potential of dopamine agonists in the treatment of type 2 diabetes mellitus. Environmental science and pollution research international, 2022, Volume: 29, Issue:31 Topics: Bromocriptine; Cabergoline; Diabetes Mellitus, Type 2; Dopamine Agonists; Humans; Hyperprolactinemia; Parkinson Disease; Restless Legs Syndrome	2022
A review of dopamine agonist therapy in type 2 diabetes and effects on cardio-metabolic parameters. Primary care diabetes, 2016, Volume: 10, Issue:1 Topics: Animals; Biomarkers; Blood Glucose; Bromocriptine; Cabergoline; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Dopamine Agonists; Ergolines; Humans; Hypoglycemic Agents; Risk Factors; Treatment Outcome	2016

Trials

2 trial(s) available for cabergoline and Diabetes Mellitus, Type 2

Article	Year
Effects of cabergoline on blood glucose levels in type 2 diabetic patients: A double-blind controlled clinical trial. Medicine, 2016, Volume: 95, Issue:40 Topics: Blood Glucose; Cabergoline; Diabetes Mellitus, Type 2; Dopamine Agonists; Double-Blind Method; Ergolines; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged	2016
Cabergoline effect on blood sugar in type 2 diabetic patients with oral agent failure. The Medical journal of Malaysia, 2012, Volume: 67, Issue:4 Topics: Adult; Blood Glucose; Cabergoline; Diabetes Mellitus, Type 2; Dopamine Agonists; Ergolines; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Treatment Failure	2012

Other Studies

1 other study(ies) available for cabergoline and Diabetes Mellitus, Type 2

Article	Year
Management of type 2 diabetes mellitus associated with pituitary gigantism. Pituitary, 2007, Volume: 10, Issue:4 Topics: Adenoma; Adolescent; Antineoplastic Agents; Cabergoline; Combined Modality Therapy; Diabetes Mellitus, Type 2; Ergolines; Gigantism; Human Growth Hormone; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting; Male; Metformin; Pituitary Neoplasms; Radiotherapy	2007

Article

Year

Management of type 2 diabetes mellitus associated with pituitary gigantism.

Pituitary, 2007, Volume: 10, Issue:4

Topics: Adenoma; Adolescent; Antineoplastic Agents; Cabergoline; Combined Modality Therapy; Diabetes Mellitus, Type 2; Ergolines; Gigantism; Human Growth Hormone; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting; Male; Metformin; Pituitary Neoplasms; Radiotherapy

2007